SMI
12.831,85
PKT
+9,61
PKT
+0,07
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.10.12 | Sonova neutral | Sarasin Research | |
| 22.10.12 | Nestlé halten | Independent Research GmbH | |
| 22.10.12 | Nestlé overweight | Morgan Stanley | |
| 22.10.12 | UBS sell | Société Générale Group S.A. (SG) | |
| 22.10.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 19.10.12 | Holcim hold | Deutsche Bank AG | |
| 19.10.12 | Zurich Insurance neutral | Sarasin Research | |
| 19.10.12 | Holcim hold | Deutsche Bank AG | |
| 19.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 19.10.12 | Zurich Insurance hold | Deutsche Bank AG | |
| 19.10.12 | Nestlé outperform | Exane-BNP Paribas SA | |
| 19.10.12 | Holcim neutral | J.P. Morgan Cazenove | |
| 19.10.12 | Swiss Re neutral | Sarasin Research | |
| 19.10.12 | ABB (Asea Brown Boveri) neutral | Nomura | |
| 19.10.12 | Zurich Insurance neutral | Exane-BNP Paribas SA | |
| 19.10.12 | Holcim overweight | J.P. Morgan Cazenove | |
| 19.10.12 | Nestlé hold | Vontobel Research | |
| 19.10.12 | Swiss Re buy | Vontobel Research | |
| 18.10.12 | Zurich Insurance neutral | Credit Suisse Group | |
| 18.10.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 18.10.12 | UBS overweight | Morgan Stanley | |
| 18.10.12 | UBS equal-weight | Morgan Stanley | |
| 18.10.12 | Swiss Life buy | Nomura | |
| 18.10.12 | Givaudan sell | Goldman Sachs Group Inc. | |
| 18.10.12 | Nestlé buy | Sarasin Research | |
| 18.10.12 | Givaudan outperform | Exane-BNP Paribas SA | |
| 18.10.12 | UBS buy | Deutsche Bank AG | |
| 18.10.12 | UBS hold | Deutsche Bank AG | |
| 18.10.12 | Nestlé outperform | Cheuvreux SA | |
| 18.10.12 | Nestlé hold | Vontobel Research | |
| 18.10.12 | Zurich Insurance hold | Société Générale Group S.A. (SG) | |
| 18.10.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 18.10.12 | Zurich Insurance outperform | Keefe, Bruyette & Woods, Inc. | |
| 17.10.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 17.10.12 | Zurich Insurance halten | Independent Research GmbH | |
| 17.10.12 | Novartis reduce | Vontobel Research | |
| 17.10.12 | Givaudan hold | Vontobel Research | |
| 17.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 17.10.12 | Zurich Insurance neutral | Sarasin Research | |
| 17.10.12 | Zurich Insurance hold | Vontobel Research |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.